Theme hub · 41 companies
Gene therapy stocks
Heavily traded in Gene therapy
Turnover over $10M/day12 of about 40 companies in this theme turn over more than $10M in a typical session. Largest market value first. Data as of Oct 30, 2026.
| Company | Turnover | 1Y return | Next report |
|---|---|---|---|
| KRYSKrystal Biotech, Inc. | $73.46M | +75.39% | Reports Nov 2, 2026 |
| BEAMBeam Therapeutics Inc. | $47.68M | +16.43% | Reports Nov 3, 2026 |
| PGENPrecigen, Inc. | $29.09M | +65.59% | Reports Nov 12, 2026 |
| SRPTSarepta Therapeutics, Inc. | $49.52M | −18.00% | Reports Nov 5, 2026 |
| NTLAIntellia Therapeutics, Inc. | $52.33M | +0.84% | Reports Nov 5, 2026 |
| QUREuniQure N.V. | $33.86M | −64.16% | Reports Nov 9, 2026 |
| TSHATaysha Gene Therapies, Inc. | $14.58M | −15.77% | Reports Nov 4, 2026 |
| PRMEPrime Medicine, Inc. | $17.14M | +15.42% | Reports Nov 6, 2026 |
KRYS+75.39%$73.46MReports Nov 2, 2026Pre-earnings analysisBEAM+16.43%$47.68MReports Nov 3, 2026Pre-earnings analysisPGEN+65.59%$29.09MReports Nov 12, 2026Pre-earnings analysisSRPT−18.00%$49.52MReports Nov 5, 2026Pre-earnings analysisNTLA+0.84%$52.33MReports Nov 5, 2026Pre-earnings analysisQURE−64.16%$33.86MReports Nov 9, 2026Pre-earnings analysisTSHA−15.77%$14.58MReports Nov 4, 2026Pre-earnings analysisPRME+15.42%$17.14MReports Nov 6, 2026Pre-earnings analysisTurnover over $10M/day
Turnover is the median value traded in one session, measured over the past 50 sessions. It describes trading activity in a stock and nothing about the company behind it.
Table
41 companies, largest market value first.
Data as of Oct 30, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| KRYS | Krystal Biotech, Inc. | $9.61B | Mid cap | +75.39% |
| BEAM | Beam Therapeutics Inc. | $2.98B | Mid cap | +16.43% |
| PGEN | Precigen, Inc. | $2.37B | Mid cap | +65.59% |
| SRPT | Sarepta Therapeutics, Inc. | $2.04B | Mid cap | −18.00% |
| NTLA | Intellia Therapeutics, Inc. | $1.85B | Small cap | +0.84% |
| QURE | uniQure N.V. | $1.75B | Small cap | −64.16% |
| TSHA | Taysha Gene Therapies, Inc. | $1.38B | Small cap | −15.77% |
| PRME | Prime Medicine, Inc. | $950.41M | Small cap | +15.42% |
| MGTX | MeiraGTx Holdings plc | $932.10M | Small cap | +8.68% |
| FDMT | 4D Molecular Therapeutics, Inc. | $706.02M | Small cap | +12.01% |
| SLDB | Solid Biosciences Inc. | $685.17M | Small cap | +16.39% |
| C2RS34.SA | CRISPR Therapeutics AG | $657.39M | Small cap | −16.37% |
| NGNE | Neurogene Inc. | $576.73M | Small cap | −11.78% |
| RGNX | REGENXBIO Inc. | $489.16M | Small cap | −42.29% |
| EDIT | Editas Medicine, Inc. | $449.99M | Small cap | −3.62% |
| BNTC | Benitec Biopharma Inc. | $308.07M | Small cap | −45.39% |
| IRD | Opus Genetics, Inc. | $303.66M | Small cap | +84.34% |
| RCKT | Rocket Pharmaceuticals, Inc. | $283.22M | Small cap | −32.80% |
| ABEO | Abeona Therapeutics Inc. | $260.76M | Small cap | −8.62% |
| LXEO | Lexeo Therapeutics, Inc. | $256.94M | Small cap | −69.12% |
| OCGN | Ocugen, Inc. | $252.37M | Small cap | −50.39% |
| KRRO | Korro Bio, Inc. | $209.10M | Small cap | −63.39% |
| DTIL | Precision BioSciences, Inc. | $205.36M | Small cap | −11.74% |
| VYGR | Voyager Therapeutics, Inc. | $108.45M | Small cap | −61.82% |
| ENGN | enGene Therapeutics Inc. | $102.53M | Small cap | −79.13% |
| TNYA | Tenaya Therapeutics, Inc. | $92.04M | Micro cap | −72.14% |
| SGMO | Sangamo Therapeutics, Inc. | $91.14M | Micro cap | −56.86% |
| 4563.T | AnGes, Inc. | $70.74M | Micro cap | −68.18% |
| 0R1D.L | Sangamo Therapeutics, Inc. | $31.87M | Micro cap | −85.20% |
| MGX | Metagenomi Therapeutics, Inc. | $31.36M | Micro cap | −64.67% |
| GNTA | Genenta Science S.p.A. | $29.89M | Micro cap | −79.40% |
| 4883.T | Modalis Therapeutics Corporation | $18.51M | Micro cap | −62.16% |
| PASG | Passage Bio, Inc. | $11.33M | Micro cap | −52.62% |
| GNPX | Genprex, Inc. | $1.65M | Micro cap | −69.28% |
| 0VRQ.L | CRISPR Therapeutics AG | — | — | −32.36% |
| 4BB.L | 4basebio PLC | — | Small cap | −27.59% |
| ALSEN.PA | Sensorion SA | — | Small cap | +2134.29% |
| CRNA.OL | Circio Holding ASA | — | Mid cap | +857.52% |
| CRNAO.OL | Circio Holding ASA | — | — | +1024.74% |
| GENF.L | Genflow Biosciences plc | — | — | −18.60% |
| SIGHT.PA | GenSight Biologics S.A. | — | — | −46.35% |
Covers ~23,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Price and the 52-week distance are in the currency the stock trades in; only market values are converted.
We cover 41 companies grouped under the Gene therapy theme. The median market value in the group is $293.44M. Among the 30 with a price from the latest session, the median move over the past trading day is −0.43%. 38% of the 39 with a 200-day average trade above it. Price change over the past year runs from −69.3% to +75.4% across the middle 80 percent of the group, with a median of −27.6%.
Other lists in this group
Gene therapyAdvanced packagingAerospaceAgriculture and agribusinessAI applicationsAI chipsAI datacenter infrastructureAirlinesAlcoholic beveragesAlternative asset managersAluminumApparel and footwearAR VR mixed realityAsset managementAuto partsAutomotive OEMsAutonomous driving softwareBeauty and personal careBiofuelsBitcoin miningBlockchain platformsBrokerage and exchangesBuilding productsCannabisAll stocks
The other 156 themes
Carbon captureCarbon creditsCasual diningCell therapyCell tower REITCement and aggregatesCoal miningCobaltCommercial office REITCommodity chemicalsComputer visionConstruction and engineeringConsumer financeContainers and packagingContract research CDMOCopper miningCredit rating and dataCruise linesCryptocurrency and digital assetsCybersecurityData platformsDatacenter coolingDatacenter powerDatacenter REITDefense electronicsDefense prime contractorsDental careDeveloper toolsDiabetes careDiagnosticsDiamonds and gemstonesDiscount retailDrones and UAVEcommerce marketplacesEcommerce platformsEdge computingEdtechElectrical equipmentEnergy storageEsportsEV batteriesEV chargingEV makersFast food and quick serviceFintech softwareGambling and casinosGaming softwareGenerative AIGeneric drugsGeothermalGLP 1 and obesityGold miningGPU cloud computeGraphiteGrocery and supermarketsHealth insuranceHealthcare REITHealthtech softwareHome improvementHomebuildersHospitals and providersHotel REITHotels and hospitalityHousehold productsHR techHVAC and controlsHydroelectricHydrogen economyIndustrial automationIndustrial gasesIndustrial machineryIndustrial REITInsurance brokersInvestment bankingIoT platformsIron oreLife insuranceLife science toolsLithium miningLogistics and 3PLLong term careLumber and forestryLuxury goodsMarine shippingMartech adtechMedical devicesMemory storage semisMissiles and munitionsMoney center banksMortgage financeMortgage REITmRNA platformsNatural gas utilitiesNeobanks and digital banksNeuroscienceNickelNon alcoholic beveragesNuclear powerOil and gas explorationOil and gas midstreamOil and gas refiningOil and gas servicesOncologyOnline travelPackaged foodsPayment processingPet carePharmaceuticals large capPotash fertilizerProperty casualty insurancePsychedelic therapeuticsQuantum computingRail transportRare diseaseRare earthsReal estate servicesRegional banksRegulated electric utilitiesReinsuranceRenewable energy developersResidential REITRetail REITRide hailing and deliveryRobotics hardwareSaaSSelf storage REITSemiconductor designSemiconductor equipmentSemiconductor manufacturingShipbuildingSilver miningSocial mediaSolarSpace launch and satellitesSpecialty chemicalsSpecialty financeSpecialty REITSpecialty retailSpeech and audio AISteelStreaming mediaSupply chain softwareSurgical roboticsTelecom equipmentTelecom infrastructureTelemedicineTobacco and nicotineTravel and leisureTrucking and LTLUranium miningVeterinary and animal healthVision and ophthalmologyWaste managementWater utilities and treatmentWealth managementWind